These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
195 related articles for article (PubMed ID: 10805834)
1. The impact of colorectal cancer screening on life expectancy. Inadomi JM; Sonnenberg A Gastrointest Endosc; 2000 May; 51(5):517-23. PubMed ID: 10805834 [TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness of colonoscopy in screening for colorectal cancer. Sonnenberg A; Delcò F; Inadomi JM Ann Intern Med; 2000 Oct; 133(8):573-84. PubMed ID: 11033584 [TBL] [Abstract][Full Text] [Related]
3. Fecal occult blood and flexible sigmoidoscopy screening for colorectal cancer: modeling the impact on colonoscopy requirements and cancer detection rates. Olynyk JK; Platell CF; Collett JA J Gastroenterol Hepatol; 2001 Apr; 16(4):389-92. PubMed ID: 11354276 [TBL] [Abstract][Full Text] [Related]
4. Is there endoscopic capacity to provide colorectal cancer screening to the unscreened population in the United States? Seeff LC; Manninen DL; Dong FB; Chattopadhyay SK; Nadel MR; Tangka FK; Molinari NA Gastroenterology; 2004 Dec; 127(6):1661-9. PubMed ID: 15578502 [TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness of colorectal cancer screening: comparison of community-based flexible sigmoidoscopy with fecal occult blood testing and colonoscopy. O'Leary BA; Olynyk JK; Neville AM; Platell CF J Gastroenterol Hepatol; 2004 Jan; 19(1):38-47. PubMed ID: 14675241 [TBL] [Abstract][Full Text] [Related]
6. Which colon cancer screening test? A comparison of costs, effectiveness, and compliance. Vijan S; Hwang EW; Hofer TP; Hayward RA Am J Med; 2001 Dec; 111(8):593-601. PubMed ID: 11755501 [TBL] [Abstract][Full Text] [Related]
7. Estimation of Benefits, Burden, and Harms of Colorectal Cancer Screening Strategies: Modeling Study for the US Preventive Services Task Force. Knudsen AB; Zauber AG; Rutter CM; Naber SK; Doria-Rose VP; Pabiniak C; Johanson C; Fischer SE; Lansdorp-Vogelaar I; Kuntz KM JAMA; 2016 Jun; 315(23):2595-609. PubMed ID: 27305518 [TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness of screening for colorectal cancer in the general population. Frazier AL; Colditz GA; Fuchs CS; Kuntz KM JAMA; 2000 Oct; 284(15):1954-61. PubMed ID: 11035892 [TBL] [Abstract][Full Text] [Related]
9. Endoscopic requirements of colorectal cancer screening programs in average-risk population. Estimation according to a Markov model. Rodríguez-Moranta F; Trapero-Bertran M; Castells A; Mas-Canal X; Balaguer F; Pellisé M; Gonzalo V; Ocaña T; Trilla A; Piqué JM Gastroenterol Hepatol; 2008; 31(7):405-12. PubMed ID: 18783684 [TBL] [Abstract][Full Text] [Related]
10. Screening for colorectal cancer with fecal occult blood testing and sigmoidoscopy. Winawer SJ; Flehinger BJ; Schottenfeld D; Miller DG J Natl Cancer Inst; 1993 Aug; 85(16):1311-8. PubMed ID: 8340943 [TBL] [Abstract][Full Text] [Related]
11. Comparing risks and benefits of colorectal cancer screening in elderly patients. Ko CW; Sonnenberg A Gastroenterology; 2005 Oct; 129(4):1163-70. PubMed ID: 16230070 [TBL] [Abstract][Full Text] [Related]
12. Colorectal Cancer Screening: An Updated Modeling Study for the US Preventive Services Task Force. Knudsen AB; Rutter CM; Peterse EFP; Lietz AP; Seguin CL; Meester RGS; Perdue LA; Lin JS; Siegel RL; Doria-Rose VP; Feuer EJ; Zauber AG; Kuntz KM; Lansdorp-Vogelaar I JAMA; 2021 May; 325(19):1998-2011. PubMed ID: 34003219 [TBL] [Abstract][Full Text] [Related]
13. Evaluating test strategies for colorectal cancer screening: a decision analysis for the U.S. Preventive Services Task Force. Zauber AG; Lansdorp-Vogelaar I; Knudsen AB; Wilschut J; van Ballegooijen M; Kuntz KM Ann Intern Med; 2008 Nov; 149(9):659-69. PubMed ID: 18838717 [TBL] [Abstract][Full Text] [Related]
14. Colorectal cancer screening in asymptomaic adults: comparison of colonoscopy, sigmoidoscopy and fecal occult blood tests. Cheng TI; Wong JM; Hong CF; Cheng SH; Cheng TJ; Shieh MJ; Lin YM; Tso CY; Huang AT J Formos Med Assoc; 2002 Oct; 101(10):685-90. PubMed ID: 12517041 [TBL] [Abstract][Full Text] [Related]
15. Consequences of Increasing Time to Colonoscopy Examination After Positive Result From Fecal Colorectal Cancer Screening Test. Meester RG; Zauber AG; Doubeni CA; Jensen CD; Quinn VP; Helfand M; Dominitz JA; Levin TR; Corley DA; Lansdorp-Vogelaar I Clin Gastroenterol Hepatol; 2016 Oct; 14(10):1445-1451.e8. PubMed ID: 27211498 [TBL] [Abstract][Full Text] [Related]
16. Colorectal cancer test use--Maryland, 2002-2006. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 2007 Sep; 56(36):932-6. PubMed ID: 17851446 [TBL] [Abstract][Full Text] [Related]
17. Use of colonoscopy for colorectal cancer screening: evidence from the 2000 National Health Interview Survey. Subramanian S; Amonkar MM; Hunt TL Cancer Epidemiol Biomarkers Prev; 2005 Feb; 14(2):409-16. PubMed ID: 15734966 [TBL] [Abstract][Full Text] [Related]
18. Health benefits and cost-effectiveness of a hybrid screening strategy for colorectal cancer. Dinh T; Ladabaum U; Alperin P; Caldwell C; Smith R; Levin TR Clin Gastroenterol Hepatol; 2013 Sep; 11(9):1158-66. PubMed ID: 23542330 [TBL] [Abstract][Full Text] [Related]
19. One-time screening for colorectal cancer with combined fecal occult-blood testing and examination of the distal colon. Lieberman DA; Weiss DG; N Engl J Med; 2001 Aug; 345(8):555-60. PubMed ID: 11529208 [TBL] [Abstract][Full Text] [Related]
20. [Screening for colorectal cancer in Italy, 2010 survey]. Zorzi M; Fedato C; Grazzini G; Sassoli de' Bianchi P; Naldoni C; Pendenza M; Sassatelli R; Senore C; Visioli CB; Zappa M Epidemiol Prev; 2012; 36(6 Suppl 1):55-77. PubMed ID: 23293271 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]